Log in to your Inderes Free account to see all free content on this page.
Senzime
4.42 SEK
-3.71 %
Less than 1K followers
SEZI
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Senzime
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 6.7 | 9.3 | 11.0 | 14.0 | 35.8 | 58.5 | 104.0 |
| growth-% | 39.1 % | 17.6 % | 27.8 % | 154.8 % | 63.6 % | 77.9 % | |
| EBITDA | -24.0 | -37.0 | -73.2 | -118.4 | -116.8 | -97.8 | -99.1 |
| EBIT | -36.4 | -48.9 | -84.2 | -133.9 | -137.4 | -124.1 | -122.6 |
| Profit before taxes | -36.4 | -49.0 | -84.3 | -134.4 | -137.2 | -122.8 | -139.0 |
| Net income | -33.7 | -47.4 | -82.1 | -132.7 | -134.2 | -118.7 | -137.4 |
| EPS | -0.67 | -0.83 | -1.30 | -1.96 | -1.45 | -0.97 | -0.93 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -357.1 % | -395.9 % | -666.7 % | -843.6 % | -326.7 % | -167.3 % | -95.2 % |
| EBIT-% | -542.9 % | -523.4 % | -766.8 % | -954.5 % | -384.2 % | -212.1 % | -117.8 % |
| ROE | -20.6 % | -20.5 % | -54.5 % | -50.7 % | -35.7 % | -34.3 % | -45.1 % |
| ROI | -17.9 % | -18.3 % | -47.0 % | -41.2 % | -31.0 % | -28.0 % | -37.2 % |
Login required
This content is only available for logged in users